Rene trial update/JVs



If you look at Rene’s RNS history the company updated the market on Fosun jv 9/4/20 and treated its first stroke patient in USA 24/01/19. Surely we should have more jvs announced and confirmation that all 130 stroke patients have either been treated with stem cells or the placebo and are being monitored.

Rene should update shareholders on its trials and jvs.